89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. The company was founded on January 18, 2018 and is headquartered in San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
93
Frequently Asked Questions
What is Market Cap of 89bio Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. 89bio Inc market cap is $1.32B.
What is the 52-week high for 89bio Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. 89bio Inc 52 week high is $11.84 as of September 06, 2025.
What is the 52-week low for 89bio Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. 89bio Inc 52 week low is $4.16 as of September 06, 2025.
What is 89bio Inc stock price today?
89bio Inc stock price today is $8.87.
What was 89bio Inc stock price yesterday?
89bio Inc stock price yesterday was $8.61.
What is the PE ratio of 89bio Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. 89bio Inc’s P/E ratio is -2.46.
What is the Price-to-Book ratio of 89bio Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. 89bio Inc P/B ratio is 2.5213.
What is the 50-day moving average of 89bio Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. 89bio Inc 50-day moving average is $9.65.